Peking University People's Hospital

Peking University People's Hospital (PKUPH), founded in 1918 as China's first general hospital financed and operated by Chinese nationals, is today one of Beijing's most comprehensive academic medical centers, with over 2,600 beds across three campuses, 4.5 million annual outpatient visits, and more than 1,300 physicians.

It holds dual national designations as both the National Center for Trauma Medicine and the National Clinical Research Center for Hematologic Disease — a rare pairing that makes it simultaneously China's leading trauma system and its premier blood cancer treatment hub.

The Peking University Institute of Hematology, housed here, is the world's largest center for allogeneic and haploidentical stem cell transplantation, performing over 1,200 transplant cases per year; its pioneering protocol for half-matched bone marrow transplantation — adopted by centers in Italy, France, Israel, and South Korea — has transformed outcomes for leukemia and aplastic anemia patients who lack matched donors globally. From hematologic malignancy and CAR-T cell therapy to complex polytrauma and minimally invasive thoracic surgery, PKUPH offers a breadth and depth of subspecialty excellence rarely found at a single institution.